Verition Fund Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-42,304	Closed	-$59.6K	–	2136
2023 Q2	$59.6K	Buy	+42,304	New	+$59.6K	﹤0.01%	1743
2023 Q1	–	Sell	-10,400	Closed	-$12.2K	–	2079
2022 Q4	$12.2K	Buy	+10,400	New	+$12.2K	﹤0.01%	1536